Forest Laboratories Company News
Wed, 26 Oct 2016 22:29:24 GMT
Allergan CEO Brent Saunders Succeeds Paul Bisaro as Chairman - Wall Street Journal
Allergan PLC named Chief Executive Brent Saunders to the additional post of chairman, succeeding Paul Bisaro. Mr. Bisaro was chief executive from 2007 through 2014, and has since served as executive chairman. He will remain on the board.
Allergan PLC named Chief Executive Brent Saunders to the additional post of chairman, succeeding Paul Bisaro. Mr. Bisaro was chief executive from 2007 through 2014, and has since served as executive chairman. He will remain on the board.
Wed, 26 Oct 2016 21:53:05 GMT
Allergan's Saunders Adds Chairman Role - Orange County Business Journal
Saunders has been president and chief executive since July 2014, when the company, then called Actavis Plc, bought Forest Laboratories Inc. in New York, where Saunders had held the same roles. Bisaro was president, chief executive and chairman of ...
Saunders has been president and chief executive since July 2014, when the company, then called Actavis Plc, bought Forest Laboratories Inc. in New York, where Saunders had held the same roles. Bisaro was president, chief executive and chairman of ...
Thu, 20 Oct 2016 18:22:52 GMT
CNA C-Suite Q&A: Enumeral Identifies Opportunities In The Immunotherapy Discovery And Development Process - CNA Finance (press release)
Prior to joining Enumeral in September 2016, Wael has held senior positions at Novartis, Schering-Plough and most recently was Corporate Vice President, Global Business Development of Forest Laboratories. He holds a B.S. in biology from the American ...
Prior to joining Enumeral in September 2016, Wael has held senior positions at Novartis, Schering-Plough and most recently was Corporate Vice President, Global Business Development of Forest Laboratories. He holds a B.S. in biology from the American ...
Mon, 26 Sep 2016 22:20:17 GMT
Judge Orders Depositions Of Ex-Forest Labs Employees - Law360 (subscription)
Law360, New York (September 26, 2016, 5:47 PM EDT) -- A Boston federal judge has granted a motion to compel six new depositions of former Forest Laboratories Inc. officials in a suit over the effectiveness of Celexa and Lexapro in children, but also ...
Law360, New York (September 26, 2016, 5:47 PM EDT) -- A Boston federal judge has granted a motion to compel six new depositions of former Forest Laboratories Inc. officials in a suit over the effectiveness of Celexa and Lexapro in children, but also ...
Fri, 02 Sep 2016 04:32:31 GMT
Allergan, Adamas Pharma settle Namzaric patent litigation with Amneal Pharma - pharmabiz.com
Allergan plc, a leading global pharmaceutical company, announced that its subsidiaries Forest Laboratories, LLC, Forest Laboratories Holdings, Ltd. and Allergan USA, along with Adamas Pharmaceuticals, Inc., have entered into a settlement agreement with ...
Allergan plc, a leading global pharmaceutical company, announced that its subsidiaries Forest Laboratories, LLC, Forest Laboratories Holdings, Ltd. and Allergan USA, along with Adamas Pharmaceuticals, Inc., have entered into a settlement agreement with ...
Wed, 31 Aug 2016 15:45:16 GMT
Allergan and Adamas agree to 2025 entry for Namzaric generic in Amneal dispute - The Pharma Letter (registration)
The settlement relates to a patent infringement litigation brought by the Allergan subsidiary Forest Laboratories and Adamas, a US-based central nervous system (CNS) disorders specialist, in response to Amneal's Abbreviated New Drug Application (ANDA) ...
The settlement relates to a patent infringement litigation brought by the Allergan subsidiary Forest Laboratories and Adamas, a US-based central nervous system (CNS) disorders specialist, in response to Amneal's Abbreviated New Drug Application (ANDA) ...
Wed, 31 Aug 2016 12:30:16 GMT
Allergan and Adamas Pharma settle Namzaric patent fight with generic firm - Seeking Alpha
Allergan (NYSE:AGN) and Adamas Pharmaceuticals (NASDAQ:ADMS) settle their patent litigation against Amneal Pharmaceuticals related to Alzheimer's med NAMZARIC (memantine HCl extended release and donepezil HCl) capsules. Amneal filed an ...
Allergan (NYSE:AGN) and Adamas Pharmaceuticals (NASDAQ:ADMS) settle their patent litigation against Amneal Pharmaceuticals related to Alzheimer's med NAMZARIC (memantine HCl extended release and donepezil HCl) capsules. Amneal filed an ...
Wed, 31 Aug 2016 12:07:43 GMT
Allergan, Adamas Announce Settlement with Amneal on NAMZARIC Patent Litigation - RTT News
Allergan plc (AGN) announced that its subsidiaries Forest Laboratories, LLC, Forest Laboratories Holdings, Ltd. and Allergan USA, along with Adamas Pharmaceuticals Inc. (ADMS), have entered into a settlement agreement with Amneal Pharmaceuticals ...
Allergan plc (AGN) announced that its subsidiaries Forest Laboratories, LLC, Forest Laboratories Holdings, Ltd. and Allergan USA, along with Adamas Pharmaceuticals Inc. (ADMS), have entered into a settlement agreement with Amneal Pharmaceuticals ...
Sun, 28 Aug 2016 18:01:14 GMT
Allergan: An Undervalued Powerhouse - GuruFocus.com
In 2014, the company acquired Forest Laboratories for $25 billion. Forest Laboratories was considered a good fit for Allergan due to its strong legacy in branded specialty and primary care pharmaceuticals. In the same year, Actavis and Allergan decided ...
In 2014, the company acquired Forest Laboratories for $25 billion. Forest Laboratories was considered a good fit for Allergan due to its strong legacy in branded specialty and primary care pharmaceuticals. In the same year, Actavis and Allergan decided ...
Fri, 29 Jul 2016 01:30:31 GMT
Mayne Pharma Group settles patent infringement case - Finance News Network
Mayne Pharma Group Limited (ASX:MYX) has announced it has entered into a settlement agreement with Forest Laboratories. The settlement relates to a patent infringement lawsuit Mayne Pharma filed against Forest in December 2013 regarding Forest's ...
Mayne Pharma Group Limited (ASX:MYX) has announced it has entered into a settlement agreement with Forest Laboratories. The settlement relates to a patent infringement lawsuit Mayne Pharma filed against Forest in December 2013 regarding Forest's ...